Trials / Unknown
UnknownNCT05737771
To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of the Fixed-dose Combination of DWJ1563 Compared to the Loose Combination of DWP16001 and DWC202213
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To compare the safety and pharmacokinetic properties between the administration of DWP16001 and DWC202213 as an individual drug, and the administration of DWJ1563 as a combination drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWC202213 | DWC202213 |
| DRUG | DWJ1563 | DWJ1563 |
| DRUG | DWP16001 | DWP16001 |
Timeline
- Start date
- 2023-01-25
- Primary completion
- 2023-03-31
- Completion
- 2023-06-30
- First posted
- 2023-02-21
- Last updated
- 2023-02-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05737771. Inclusion in this directory is not an endorsement.